Claris Lifesciences is trading higher by 2% at Rs 202 ahead of board meeting today to consider a share buyback proposal. The board will also consider an interim dividend to exiting equity shareholders.
“The board of directors of the pharmaceutical company will meet on January 07, 2014, to consider, a proposal for buy back of the equity shares of the company,” Claris Lifesciences said in a BSE filing.
Currently, the promoters held 60.21% stake in the company. Foreign institutional investors held 14.77%, followed by domestic institutional investors (11.42%), while the remaining 13.60% stakes are with the individual shareholders and others.
The stock opened at Rs 202 and touched high of Rs 203 on the BSE. Till 0945 hours, around 86,000 shares have changed hands on the counter.
“The board of directors of the pharmaceutical company will meet on January 07, 2014, to consider, a proposal for buy back of the equity shares of the company,” Claris Lifesciences said in a BSE filing.
Currently, the promoters held 60.21% stake in the company. Foreign institutional investors held 14.77%, followed by domestic institutional investors (11.42%), while the remaining 13.60% stakes are with the individual shareholders and others.
The stock opened at Rs 202 and touched high of Rs 203 on the BSE. Till 0945 hours, around 86,000 shares have changed hands on the counter.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%